SEC Filings

S-1/A
AVEXIS, INC. filed this Form S-1/A on 02/09/2016
Entire Document
 

Table of Contents


CAPITALIZATION

          The following table sets forth our cash and cash equivalents, and our capitalization as of September 30, 2015:

    on an actual basis;

    on a pro forma basis to give effect to (i) the amendment and restatement of our license agreement with NCH in January 2016, which terminated NCH's right to sell shares of common stock that it owns back to us in certain circumstances; (ii) the automatic conversion of all outstanding shares of our preferred stock into an aggregate of 8,695,662 shares of common stock, which will occur automatically upon the closing of this offering; and (iii) the adoption of our amended and restated certificate of incorporation upon the closing of this offering; and

    on a pro forma as adjusted basis to give further effect to our issuance and sale of 4,250,000 shares of common stock in this offering at an assumed initial public offering price of $20.00 per share, which is the midpoint of the price range set forth on the cover page of this prospectus, after deducting the estimated underwriting discounts and estimated offering expenses payable by us.

          You should read this information in conjunction with our consolidated financial statements and the related notes appearing at the end of this prospectus, the "Management's Discussion and Analysis of Financial Condition and Results of Operations" section and other financial information contained in this prospectus.

 
  As of September 30, 2015  
 
 
Actual
 
Pro Forma
 
Pro Forma
as Adjusted
 

Cash and cash equivalents

  $ 69,706,462   $ 69,706,462   $ 146,256,462  

Redeemable common stock; par value $0.0001 per share, 456,043 shares issued and outstanding actual, and no shares issued and outstanding pro forma and pro forma as adjusted at September 30, 2015

  $ 1,032,909   $   $  

Stockholders' equity:

                   

Preferred stock:

                   

Class B-1 preferred stock; par value $0.0001 per share, 3,278,938 shares authorized, 3,237,538 shares issued and outstanding, actual; and no shares authorized, issued and outstanding pro forma and pro forma as adjusted

    324          

Class B-2 preferred stock; par value $0.0001 per share, 326,557 shares authorized, and no shares issued and outstanding, actual; and no shares authorized, issued and outstanding pro forma and pro forma as adjusted

             

Class C preferred stock; par value $0.0001 per share, 2,365,020 shares authorized, and 2,365,020 shares issued and outstanding, actual; and no shares authorized, issued and outstanding pro forma and pro forma as adjusted

    237          

Class D preferred stock; par value $0.0001 per share, 3,105,000 shares authorized, 3,093,104 shares issued and outstanding, actual; and no shares authorized, issued and outstanding, pro forma and pro forma as adjusted

    309          

Undesignated preferred stock; par value $0.0001 per share, 1,000,000 shares authorized and no shares issued and outstanding, actual; 10,000,000 shares authorized, no shares issued and outstanding pro forma and pro forma as adjusted

             

Common stock; par value $0.0001 per share, 22,080,000 shares authorized, 6,748,104 shares issued and outstanding, actual; and 100,000,000 shares authorized and 15,899,809 shares issued and outstanding pro forma; 100,000,000 shares authorized, 20,149,809 shares issued outstanding, pro forma as adjusted

    675     1,591     2,016  

Additional paid-in capital

    108,155,371     109,188,234     185,737,809  

Accumulated deficit

    (45,389,656 )   (45,389,656 )   (45,389,656 )

Total stockholders' equity

    62,767,260     63,800,169   $ 140,350,169  

Total capitalization

  $ 63,800,169   $ 63,800,169   $ 140,350,169  

77



© AveXis, Inc. All Rights Reserved.